Reduction of Alcohol-Dependent Lung Pathological Features in Rats Treated with Fenofibrate

Diego A Rojas, Krishna Coronado, Diliana Pérez-Reytor, Eduardo Karahanian, Andreas Schwingshackl · 2024

Read Reduction of Alcohol-Dependent Lung Pathological Features in Rats Treated with Fenofibrate by Diego A Rojas, Krishna Coronado, Diliana Pérez-Reytor, Eduardo Karahanian, Andreas Schwingshackl (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11641378.txt.

Description

Diego Rojas and co-authors test whether a lipid drug can undo alcohol's damage to rat lungs, in a 2024 study. Heavy drinking stirs body-wide inflammation, and lungs pay with swelling, mucus flood, and scar tissue that breeds infection. Fenofibrate, a fat-drug that fires a cell switch called PPAR alpha, is known to cool inflammation elsewhere. Rats drank alcohol, with or without the drug to follow.

Alcohol alone thickened the lungs with immune cells and raised flame signals inside them. It also pushed up a mucus protein and laid collagen collars around the airways. Fenofibrate after alcohol pulled each mark back down, the collagen near to the level of sober controls. The authors read alcohol as a clear lung toxin in this model. They glimpse a second career for the old drug, as a lung anti-inflammatory worth testing in drink-linked lung disease.

Catalog record

CREATORDiego A Rojas, Krishna Coronado, Diliana Pérez-Reytor, Eduardo Karahanian, Andreas Schwingshackl
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11641378

Browse the full library · About the Tower of Babel